CRS: BJMC
Position: Lab Manager
Position: TB Laboratory Coordinator
CRS:
Position:
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
